Atara biotherapeutics to participate in the goldman sachs 44th annual global healthcare conference

Thousand oaks, calif.--(business wire)---- $atra #cart--atara biotherapeutics, inc. (nasdaq: atra), a leader in t-cell immunotherapy, leveraging its novel allogeneic epstein-barr virus (ebv) t-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that pascal touchon, president and chief executive officer, will participate in a fireside chat at the goldman sachs 44th annual global healthcare conference on wednesday, june 14, 2023 at 4:00 p.m. pdt / 7.
ATRA Ratings Summary
ATRA Quant Ranking